SCHEMBL6427736

SCHEMBL6427736

O=C(OC[C@@H]1C[CH][C@H](n2cnc3c(Cl)ncnc32)O1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.46
▸ TYMP P19971 1/20 0.44
▸ STING1 Q86WV6 2/20 0.40
▸ ABCB1 P08183 1/20 0.39
▸ P2RX3 P56373 1/20 0.38
▸ P2RX4 Q99571 1/20 0.38
▸ P2RX2 Q9UBL9 1/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ RPS6KA3 P51812 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163915 0.82 LMNA (0.53) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL13970745 0.82 LMNA (0.53) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL14615870 0.82 TYMP (0.50) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL3163908 0.82 LMNA (0.53) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL20059072 0.82 TYMP (0.50) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL6429891 0.81 ADORA1 (0.55) —
SCHEMBL5389026 0.79 LMNA (0.46) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL5389035 0.79 LMNA (0.46) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL14593730 0.79 LMNA (0.46) LMNATYMPSTING1ABCB1P2RX3
SCHEMBL7699396 0.79 LMNA (0.45) LMNATYMPSTING1ABCB1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590359-A2 PARTIAL AND FULL AGONISTS OF A sb 1 /sb ADENOSINE RECEPTORS CV Therapeutics Inc. (US) 2005-11-02 — — EP disclosed
WO-2004069185-A2 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS CV THERAPEUTICS INC. (US) 2004-08-19 — — WO disclosed
Send feedback